JBS invests $150M in Oman multiprotein hub JV
JBS N.V. plans a major expansion in the Middle East by creating a joint venture with Oman Food Investment Holding Company to build a multiprotein production hub in Oman.
Rhea-AI Filing Summary
JBS N.V. plans a major expansion in the Middle East by creating a joint venture with Oman Food Investment Holding Company to build a multiprotein production hub in Oman. JBS will invest USD 150 million in equity for an 80% stake in the JV, implying a pre-money enterprise value of USD 167.5 million.
The JV will own existing poultry and red meat businesses in Oman and fund completion of the A’Namaa integrated poultry plant and Al Bashayer’s beef and lamb facility. Once completed, the operation is expected to reach static industrial capacity of about 300,000 tons per year, processing roughly 1,000 cattle, 5,000 lambs, and 600,000 chickens daily.
Production is expected to begin within six months for beef and lamb and within 12 months for poultry, with more than 3,000 direct jobs anticipated over five years. Closing of the transaction depends on customary conditions precedent, including regulatory approvals.
Positive
- None.
Negative
- None.
Insights
JBS commits $150M to an Oman JV to build a sizable halal multiprotein hub.
JBS is using a joint venture with Oman Food Investment Holding Company to anchor a multiprotein platform serving the Middle East and export halal markets. The company will inject USD 150 million of equity for an 80% ownership stake, with a pre-money enterprise value of USD 167.5 million for the JV.
The project consolidates poultry, beef, and lamb operations in Oman into a Netherlands-based JV, funding completion of the A’Namaa poultry plant and Al Bashayer beef and lamb facility. Planned static capacity of about 300,000 tons per year indicates meaningful regional scale, with daily throughput targets across cattle, lambs, and chickens.
Execution depends on finishing construction, achieving the stated capacities, and obtaining required regulatory approvals, which are listed as conditions precedent to closing. Management expects beef and lamb production within six months and poultry within 12 months, with more than 3,000 direct jobs projected in Oman over five years.
FAQ
What is JBS (JBS) announcing in its February 2026 Form 6-K?
How much is JBS investing in the new Oman multiprotein hub JV?
What production capacity does JBS expect from the Oman multiprotein hub?
When is production expected to start at JBS’s Oman joint venture facilities?
How many jobs could JBS’s Middle East multiprotein hub create in Oman?
What conditions must be met before JBS’s Oman joint venture is completed?
AI-generated analysis. How Rhea-AI works. Not financial advice.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report of Foreign Private Issuer Pursuant to Rule 13a-16 or
15d-16 of the Securities Exchange Act of 1934
For the month of February 2026
Commission File Number: 001-42678
JBS N.V.
(Exact Name as Specified in its Charter)
N/A
(Translation of registrant’s name into English)
Stroombaan 16, 5th Floor,
1181 VX, Amstelveen, Netherlands
(Address of principal executive offices)
(Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.)
Form 20-F: ☒ Form 40-F: ☐
EXHIBIT INDEX
| Exhibit Number |
Description of Document | |
| 99.1 | Material fact (Multiprotein Hub in the Middle East) |
1
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Date: February 08, 2026
| JBS N.V. | ||
| By: | /s/ Guilherme Perboyre Cavalcanti | |
| Name: | Guilherme Perboyre Cavalcanti | |
| Title: | Chief Financial Officer | |
2
Exhibit 99.1
MATERIAL FACT
JBS INVESTS US$150 MILLION IN MULTIPROTEIN HUB IN THE MIDDLE EAST
JBS N.V. (“JBS”) informs its shareholders and the market in general that it has entered into a Share Purchase Agreement (SPA) with Oman Food Investment Holding Company S.A.O.C. (“OFC” and, together with JBS, “Parties”) to establish a Joint Venture between the Parties through a company based in the Netherlands (“JV”), which will own 100% of the businesses currently operated in Oman by the companies A’Namaa Poultry Co. SAOC, responsible for an integrated project for the production and processing of chicken meat, and Al Bashayer Meat Company SAOC, dedicated to the confinement and processing of beef and lamb meat.
The JV will aim to establish a protein production hub in Oman to ensure food security for the population, in accordance with the Sultanate’s Vision 2040, and to position the country as a center for the production of halal products suitable for export to various markets.
JBS will invest USD 150 million in equity in the JV, holding 80% of its shares, while OFC will hold the remaining 20%. This investment implies an Enterprise Value pre-money of USD 167.5 million for the JV.
The resources will be used mainly for the completion of (i) the A’Namaa integrated poultry plant, located in the Ibri region in northern Oman, approximately 380 kilometers west of Muscat (the nation’s capital) and 280 kilometers south of Dubai, United Arab Emirates; and (ii) the Al Bashayer’s beef and lamb processing facility in Thumrait, in southern Oman.
With this, we estimate that the operation will reach a static industrial production capacity of approximately 300 thousand tons per year. This capacity corresponds to the daily processing of approximately 1,000 head of cattle, 5,000 lambs, and 600,000 chicken. Production is expected to start within six months for beef and lamb, and within 12 months for poultry.
We estimate that the completion of the project will generate more than 3,000 direct jobs over the next five years in Oman throughout the entire value chain, contributing significantly to local economic development, the qualification of the workforce and the growth of Oman's agri-food sector.
The consummation of the transaction is subject to compliance with usual conditions precedent for transactions of this nature, including applicable regulatory approvals.
JBS will keep the market duly informed of the transaction's evolution in accordance with current legislation.
Amstelvenn, February 8, 2026.
Guilherme Perboyre Cavalcanti
Global CFO and Investor Relations Officer
Forward-Looking Statements
This notice contains certain statements, including statements relating to business plans and objectives, and the assumptions upon which those statements are based, that are “forward-looking statements,” as defined under the Private Securities Litigation Reform Act of 1995. These forward-looking statements are generally identified by the words “anticipate,” “believe,” “estimate,” “expect,” “future,” “intend,” “may,” “opportunity,” “outlook,” “plan,” “project,” “should,” “strategy,” “will,” “would,” “will be,” “will continue,” “will likely result” and similar expressions. These statements are based on the current expectations of the management of JBS and are subject to uncertainty and to changes in circumstances. In addition, these statements are based on a number of assumptions that are subject to change. Many factors could cause actual results to differ materially from these forward-looking statements including unforeseen liabilities, future capital expenditures, revenues, expenses, earnings, synergies, economic performance, indebtedness, financial condition, losses, future prospects, business and management strategies for the management and expansion and growth of JBS’ operations, as well as the risk factors discussed in the final prospectus, dated April 22, 2025 and filed by the Company with the United States Securities and Exchange Commission, relating to the Company’s registration statement on Form F-4 (File No. 333-273211). While the list of factors presented here is considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on JBS’ consolidated financial condition, results of operations or liquidity. Forward-looking statements included herein are made as of the date hereof, and JBS undertakes no obligation to update publicly such statements to reflect subsequent events or circumstances.